Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
The dose-effect curve of morphine for locomotor activity was shifted downwards in C57Bl/6 mice pretreated with HS014 and in A(y) mice
Tagalakis AD
TG100801 or TG-100801 is a dual inhibitor of both VEGFr2 and the Src family (Src and YES) kinases as a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration
NCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
and steatosis in alcoholic liver disease mouse model
Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride Catalog No.:M17506-C The dose-effect curve of morphineLenalidomide propargyl C2 amido Ph NH2 hydrochloride incorporates a cereblon (CRBN) ligand for the E3 ubiquitin ligase and a linker. Lenalidomide propargyl C2 amido Ph NH2 hydrochloride can be used to design the PROTAC MD 224 (HY 114312). Product information Molecular Weight: 480. 94 Formula: C25H25ClN4O4 Chemical Name: 4 amino N [5 [2 (2, 6 dioxopiperidin 3 yl) 1 oxo 3H isoindol 4 yl]pent 4 ynyl]benzamide; hydrochloride Smiles: Cl.